M. S. Saag

3.8k citations

12 papers · 1.6k indexed · 1 hit paper · h-index 9

Impact in

Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Virology top 5%
- HIV Research and Treatment

Papers in ⓘ

Virology 3
- HIV Research and Treatment 3
Infectious Diseases 9
- HIV/AIDS Research and Interventions 6
- HIV/AIDS drug development and treatment 5

Co-authors: Robert A. Larsen (1 shared paper)John R. Perfect (1 shared paper)William G. Powderly (1 shared paper)P. G. Pappas (1 shared paper)William E. Dismukes (1 shared paper)Jack D. Sobel (1 shared paper)Heidi M. Crane (3 shared papers)Joe Eron (2 shared papers)
Journals: Clinical Infectious Diseases (4 papers)HIV Medicine (1 paper)Women & Health (1 paper)Journal of Hepatology (1 paper)American Journal of Epidemiology (1 paper)
Partner nations: United States United Kingdom Switzerland

In The Last Decade

M. S. Saag

12 papers receiving 1.5k citations

Hit Papers

align trajectories log scale

Practice Guidelines for the Management of Cryptococcal Disease 2000 · 781 citations

Peers

Countries citing papers authored by M. S. Saag

Since Specialization

Citations

This map shows the geographic impact of M. S. Saag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Saag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Saag more than expected).

Fields of papers citing papers by M. S. Saag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Saag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Saag. The network helps show where M. S. Saag may publish in the future.

Co-authors

The 25 scholars most cited alongside M. S. Saag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. S. Saag Line = papers co-authored together M. S. Saag links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Practice Guidelines for the Management of Cryptococcal Disease Clinical Infectious Diseases ·M. S. Saag, Richard Graybill, Robert A. Larsen, P. G. Pappas, John R. Perfect, William G. Powderly, Jack D. Sobel, William E. Dismukes, (unknown) Hit paper breakdown →	2000	781
2	Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems International Journal of Epidemiology ·Mari M. Kitahata, Benigno Rodríguez, Richard Haubrich, S Boswell, William C. Mathews, Michael M. Lederman, William B. Lober, Stephen E. Van Rompaey, Heidi M. Crane, R. D Moore, Melanie Bertram, James Kahn, M. S. Saag	2008	206
3	Viremia Copy-Years Predicts Mortality Among Treatment-Naive HIV-Infected Patients Initiating Antiretroviral Therapy Clinical Infectious Diseases ·Michael J. Mugavero, Sonia Napravnik, S. R. Cole, Joe Eron, Brandyn Lau, Heidi M. Crane, M. M. Kitahata, James H. Willig, Richard D. Moore, Steven G. Deeks, M. S. Saag	2011	106
4	HIV Discrimination and the Health of Women Living with HIV Women & Health ·Gina M. Wingood, Ralph J. DiClemente, Isis S. Mikhail, Donna Hubbard McCree, Susan L. Davies, James W. Hardin, Shani Harris Peterson, Edward W. Hook, M. S. Saag	2007	99
5	Trends in AIDS-Defining and Non--AIDS-Defining Malignancies among HIV-Infected Patients: 1989-2002 Clinical Infectious Diseases ·Roger Bedimo, Ray Y. Chen, Neil A. Accortt, James L. Raper, Charles E. Linn, Jeroan J. Allison, J W Dubay, M. S. Saag, Craig Hoesley	2004	94
6	The effect of mode of administration on Medical Outcomes Study health ratings and EuroQol scores in AIDS Quality of Life Research ·Albert W. Wu, Denise L. Jacobson, R. A. Berzon, Dennis A. Revicki, Chantal M.A.M. van der Horst, Carl J. Fichtenbaum, M. S. Saag, Lorna A. Lynn, David Hardy, Judith Feinberg	1997	90
7	Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden American Journal of Epidemiology ·Stephen R. Cole, Sonia Napravnik, M. J. Mugavero, Brandyn Lau, Joe Eron, M. S. Saag	2009	85
8	Patient Reported Outcomes in Routine Care: Advancing Data Capture for HIV Cohort Research Clinical Infectious Diseases ·Michael Kozak, M. J. Mugavero, J. Ye, Inmaculada Aban, Sarah T. Lawrence, Christa R. Nevin, James L. Raper, Cheryl B. McCullumsmith, Joseph E. Schumacher, Heidi M. Crane, M. M. Kitahata, M. S. Saag, James H. Willig	2011	67
9	Antiretroviral pill count and clinical outcomes in treatment‐naïve patients with HIV infection HIV Medicine ·Jim Young, Colette Smith, Ramón Teira, Peter Reiss, Inmaculada Jarrín, Heidi Crane, JM Miró, Antonella d’Arminio Monforte, M. S. Saag, Robert Zangerle, HC Bucher	2017	8
10	Patterns of self-reported adherence to ART in a prospective clinical cohort Kirsten Stewart, Patricia G. Greene, Stephanie Call, Andrew O. Westfall, A. Chatwood, M. S. Saag, Sissi V. Pham	1998	6
11	Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries UCL Discovery (University College London) ·Marcel Zwahlen, Rebecca Arden Harris, Margaret May, Robert S. Hogg, Dominique Costagliola, (unknown), Jennifer Gill, Gerd Fätkenheuer, (unknown), M. S. Saag, Schlomo Staszewski, Antonella d’Arminio Monforte, Jordi Casabona, Fiona Lampe, Amy C. Justice, Viktor von Wyl, Matthias Egger	2009	6
12	P1353 : A single tablet regimen of ledipasvir/sofosbuvir for 12 weeks in HCV genotype 1 or 4 infected patients with HIV-1 co-infection : The phase 3 ION-4 study Journal of Hepatology ·C. Cooper, Susanna Naggie, M. S. Saag, J.C. Yang, Luisa M. Stamm, Phillip S. Pang, John G. McHutchison, Douglas T. Dieterich, Mark Sulkowski	2015	3

About M. S. Saag

M. S. Saag is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Hepatology and Genetics, having authored 12 papers that have together received 1.6k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (6 papers), HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers), HIV-related health complications and treatments (2 papers), HIV, Drug Use, Sexual Risk (2 papers), LGBTQ Health, Identity, and Policy (1 paper), Health Systems, Economic Evaluations, Quality of Life (1 paper) and HIV/AIDS Impact and Responses (1 paper). The work is most often cited by research in Infectious Diseases (1.2k citations), Virology (217 citations), Epidemiology (1.0k citations), Emergency Medicine (225 citations) and Microbiology (6 citations). M. S. Saag has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Robert A. Larsen, John R. Perfect, William G. Powderly, P. G. Pappas, William E. Dismukes, Jack D. Sobel, Heidi M. Crane, Joe Eron, Brandyn Lau and M. J. Mugavero. Their work appears in journals such as Clinical Infectious Diseases, HIV Medicine, Women & Health, Journal of Hepatology and American Journal of Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact